NanoVita Secures Series A Funding with $20 Million Valuation

NanoVita, a decentralized science (DeSci) project, has announced the completion of its Series A funding round, achieving a post-investment valuation of $20 million. According to Foresight News, the specific amount raised in the funding round was not disclosed. The investment was backed by K24 Ventures, LandScape Capital, and WestLabs. NanoVita aims to integrate nanotechnology, AI bio-intelligence, and real-world health data to build an open on-chain health research infrastructure. The project seeks to enable widespread participation and benefit from the next generation of personalized health research and data sovereignty revolution.